Multiple sclerosis: glatiramer acetate inhibits monocyte reactivity in vitro and in vivo

ISSN： 1460-2156

Source： Brain, Vol.127, Iss.6, 2004-06, pp. : 1370-1378

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Glatiramer acetate induced acute exacerbation of autoimmune hepatitis in a patient with multiple sclerosis

By Neumann Helmut Csepregi Antal Sailer Michael Malfertheiner Peter

Journal of Neurology, Vol. 254, Iss. 6, 2007-06 ,pp. : 816-817

Springer Publishing Company

Access to resources Recommend Favorite

Blocking effects of serum reactive antibodies induced by glatiramer acetate treatment in multiple sclerosis

By Salama Hassan H.

Brain, Vol. 126, Iss. 12, 2003-12 ,pp. : 2638-2647

Oxford University Press

Access to resources Recommend Favorite

Glatiramer acetate-specific T-helper 1- and 2-type cell lines produce BDNF: implications for multiple sclerosis therapy

By Ziemssen T.

Brain, Vol. 125, Iss. 11, 2002-11 ,pp. : 2381-2391

Oxford University Press

Access to resources Recommend Favorite

Not such a bright idea: the UK risksharing scheme for beta interferon and glatiramer acetate in multiple sclerosis

PRACTICAL NEUROLOGY, Vol. 3, Iss. 4, 2003-08 ,pp. : 194-195

John Wiley & Sons Inc

Access to resources Recommend Favorite

Bacterial peptidoglycan and immune reactivity in the central nervous system in multiple sclerosis

By Schrijver I.A.

Brain, Vol. 124, Iss. 8, 2001-08 ,pp. : 1544-1554

Oxford University Press

Access to resources Recommend Favorite